Kordelas L - Search Results

1

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O'Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B. Lener T, et al. Among authors: kordelas l. J Extracell Vesicles. 2015 Dec 31;4:30087. doi: 10.3402/jev.v4.30087. eCollection 2015. J Extracell Vesicles. 2015. PMID: 26725829 Free PMC article.

2

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease.

Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. Kordelas L, et al. Leukemia. 2014 Apr;28(4):970-3. doi: 10.1038/leu.2014.41. Leukemia. 2014. PMID: 24445866 No abstract available.

3

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.

Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S; Essen HIV AlloSCT Group. Kordelas L, et al. N Engl J Med. 2014 Aug 28;371(9):880-2. doi: 10.1056/NEJMc1405805. N Engl J Med. 2014. PMID: 25162903 No abstract available.

4

CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.

Radtke S, Görgens A, Kordelas L, Schmidt M, Kimmig KR, Köninger A, Horn PA, Giebel B. Radtke S, et al. Among authors: kordelas l. Br J Haematol. 2015 Jun;169(6):868-78. doi: 10.1111/bjh.13362. Epub 2015 Mar 29. Br J Haematol. 2015. PMID: 25819405 Free article.

5

Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation.

Görgens A, Murke F, Kordelas L, Giebel B. Görgens A, et al. Among authors: kordelas l. Bone Marrow Transplant. 2016 Aug;51(8):1073-5. doi: 10.1038/bmt.2016.146. Epub 2016 May 23. Bone Marrow Transplant. 2016. PMID: 27214070 No abstract available.

6

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.

Kordelas L, Steckel NK, Horn PA, Beelen DW, Rebmann V. Kordelas L, et al. Int J Mol Sci. 2016 Oct 27;17(11):1797. doi: 10.3390/ijms17111797. Int J Mol Sci. 2016. PMID: 27801784 Free PMC article.

7

αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation.

Kordelas L, Buttkereit U, Lindemann M, Koldehoff M, Klisanin V, Horn PA, Fleischhauer K, Beelen DW. Kordelas L, et al. Bone Marrow Transplant. 2017 Dec;52(12):1668-1670. doi: 10.1038/bmt.2017.185. Epub 2017 Sep 4. Bone Marrow Transplant. 2017. PMID: 28869619 No abstract available.

8

Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles.

Giebel B, Kordelas L, Börger V. Giebel B, et al. Among authors: kordelas l. Stem Cell Investig. 2017 Oct 24;4:84. doi: 10.21037/sci.2017.09.06. eCollection 2017. Stem Cell Investig. 2017. PMID: 29167805 Free PMC article. Review.

9

Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.

Kordelas L, da Silva Nardi F, Wagner B, Ditschkowski M, Liebregts T, Lindemann M, Heinemann FM, Horn PA, Beelen DW, Rebmann V. Kordelas L, et al. Bone Marrow Transplant. 2018 Sep;53(9):1149-1156. doi: 10.1038/s41409-018-0145-1. Epub 2018 Mar 14. Bone Marrow Transplant. 2018. PMID: 29540850

10

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.

Kordelas L, Schwich E, Dittrich R, Horn PA, Beelen DW, Börger V, Giebel B, Rebmann V. Kordelas L, et al. Int J Mol Sci. 2019 Apr 2;20(7):1642. doi: 10.3390/ijms20071642. Int J Mol Sci. 2019. PMID: 30987036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page